Subex Approves 3.2 Million Stock Options at ₹7 for Employees

TECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Subex Approves 3.2 Million Stock Options at ₹7 for Employees
Overview

Subex Limited's Nomination and Remuneration Committee has approved the grant of 32,00,000 stock options to eligible employees at an exercise price of ₹7 per option, under its ESOP 2025 plan. This initiative aims to incentivize staff and align their interests with the company's long-term growth.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Subex Approves Stock Option Grant for Employees

Subex Limited announced that its Nomination and Remuneration Committee has approved the grant of 32,00,000 stock options to eligible employees. These options, issued under the company's Employees' Stock Option Plan (ESOP) 2025, carry an exercise price of ₹7 per option. The committee finalized this approval via a resolution by circulation, as detailed in a filing on March 31, 2026.

Employee Incentive and Alignment

Employee stock options are widely used by companies to attract, retain, and motivate key personnel. By offering options at a fixed price, employees can profit from future share price increases, aligning their financial interests with those of shareholders. For Subex, this grant reflects a strategy to engage its workforce.

Company and ESOP Background

Subex, founded in 1992, is an Indian enterprise software firm focused on telecom AI solutions and digital trust. Its ESOP 2025 plan was approved by the NRC and Board of Directors in December 2025, aiming to reward staff, attract talent, and promote ownership. Previously, under this plan, 6,00,000 stock options were granted in November 2025. The company's history includes corporate actions such as debt restructuring in 2016 and various acquisitions.

Potential Impact and Employee Benefit

The exercise of these stock options could lead to future dilution for existing shareholders. However, the grant price of ₹7 is notably lower than the market price of approximately ₹6.68 observed on March 27, 2026. This difference offers employees a potential financial gain upon exercising their options, reinforcing the company's strategy of employee engagement.

Key Risks and Concerns

Subex has previously faced regulatory challenges, including fines from NSE and BSE in 2024 for board composition non-compliance. Governance concerns have also been raised, such as the absence of promoter holding and a shareholder base dominated by retail investors. Financially, the company has seen stagnant revenue growth for the past decade and consistent losses since March 2023. Furthermore, a significant client concentration risk persists, with a few key customers contributing a substantial portion of its revenue.

Peer Comparison

Operating in the niche areas of telecom AI and digital trust, Subex's larger peers in the broader Indian IT services sector include TCS, Infosys, and Tech Mahindra. Tech Mahindra is considered a more direct competitor due to its significant focus on the telecom sector, aligning more closely with Subex's core business.

What to Track Next

Investors will be watching the vesting and exercise of these stock options. Key focuses include Subex's capacity for sustainable revenue growth and profitability, particularly in light of past challenges. Continued compliance with regulatory demands and improvements in governance will also be critical. Performance metrics and results from its AI platforms, such as HyperSense, will provide further insights.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.